Friday, October 28, 2016

Sporal




Sporal may be available in the countries listed below.


Ingredient matches for Sporal



Itraconazole

Itraconazole is reported as an ingredient of Sporal in the following countries:


  • Malta

  • Myanmar

  • Thailand

  • Vietnam

International Drug Name Search


Silbecor




Silbecor may be available in the countries listed below.


Ingredient matches for Silbecor



Sulfadiazine

Sulfadiazine silver (a derivative of Sulfadiazine) is reported as an ingredient of Silbecor in the following countries:


  • South Africa

International Drug Name Search


Thursday, October 27, 2016

Quedox




Quedox may be available in the countries listed below.


Ingredient matches for Quedox



Clarithromycin

Clarithromycin is reported as an ingredient of Quedox in the following countries:


  • Mexico

International Drug Name Search


Urinary Alkalinization Medications


Drugs associated with Urinary Alkalinization

The following drugs and medications are in some way related to, or used in the treatment of Urinary Alkalinization. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Ditalin




Ditalin may be available in the countries listed below.


Ingredient matches for Ditalin



Phenobarbital

Phenobarbital sodium salt (a derivative of Phenobarbital) is reported as an ingredient of Ditalin in the following countries:


  • Indonesia

Phenytoin

Phenytoin is reported as an ingredient of Ditalin in the following countries:


  • Indonesia

International Drug Name Search


Omeprazol Actavis




Omeprazol-Actavis may be available in the countries listed below.


Ingredient matches for Omeprazol-Actavis



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol-Actavis in the following countries:


  • Germany

  • Lithuania

  • Netherlands

  • Sweden

  • Switzerland

International Drug Name Search


Dexa Siozwo




Dexa Siozwo may be available in the countries listed below.


Ingredient matches for Dexa Siozwo



Dexamethasone

Dexamethasone 21-acetate (a derivative of Dexamethasone) is reported as an ingredient of Dexa Siozwo in the following countries:


  • Germany

International Drug Name Search


Synalgos-DC


Synalgos-DC is a brand name of aspirin/caffeine/dihydrocodeine, approved by the FDA in the following formulation(s):


SYNALGOS-DC (aspirin; caffeine; dihydrocodeine bitartrate - capsule; oral)



  • Manufacturer: CARACO

    Approval date: September 6, 1983

    Strength(s): 356.4MG;30MG;16MG [RLD]

Has a generic version of Synalgos-DC been approved?


No. There is currently no therapeutically equivalent version of Synalgos-DC available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Synalgos-DC. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Synalgos-DC.

See also...

  • Synalgos-DC Consumer Information (Wolters Kluwer)
  • Synalgos-DC Consumer Information (Cerner Multum)
  • Synalgos-DC Advanced Consumer Information (Micromedex)
  • Aspirin/Caffeine/Dihydrocodeine Consumer Information (Wolters Kluwer)
  • Aspirin, caffeine, and dihydrocodeine Consumer Information (Cerner Multum)
  • Dihydrocodeine, aspirin, and caffeine Advanced Consumer Information (Micromedex)

Oxycodon-HCl beta




Oxycodon-HCl beta may be available in the countries listed below.


Ingredient matches for Oxycodon-HCl beta



Oxycodone

Oxycodone hydrochloride (a derivative of Oxycodone) is reported as an ingredient of Oxycodon-HCl beta in the following countries:


  • Germany

International Drug Name Search


Wednesday, October 26, 2016

Reyataz


Reyataz is a brand name of atazanavir, approved by the FDA in the following formulation(s):


REYATAZ (atazanavir sulfate - capsule; oral)



  • Manufacturer: BRISTOL MYERS SQUIBB

    Approval date: June 20, 2003

    Strength(s): EQ 100MG BASE, EQ 150MG BASE, EQ 200MG BASE


  • Manufacturer: BRISTOL MYERS SQUIBB

    Approval date: October 16, 2006

    Strength(s): EQ 300MG BASE [RLD]

Has a generic version of Reyataz been approved?


No. There is currently no therapeutically equivalent version of Reyataz available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Reyataz. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Antivirally active heterocyclic azahexane derivatives
    Patent 5,849,911
    Issued: December 15, 1998
    Inventor(s): Fassler; Alexander & Bold; Guido & Capraro; Hans-Georg & Lang; Marc & Khanna; Satish Chandra
    Assignee(s): Novartis Finance Corporation
    There are described compounds of formula I*, ##STR1## wherein R.sub.1 is lower alkoxycarbonyl, R.sub.2 is secondary or tertiary lower alkyl or lower alkylthio-lower alkyl, R.sub.3 is phenyl that is unsubstituted or substituted by one or more lower alkoxy radicals, or C.sub.4 -C.sub.8 cycloalkyl, R.sub.4 is phenyl or cyclohexyl each substituted in the 4-position by unsaturated heterocyclyl that is bonded by way of a ring carbon atom, has from 5 to 8 ring atoms, contains from 1 to 4 hetero atoms selected from nitrogen, oxygen, sulfur, sulfinyl (--SO--) and sulfonyl (--SO.sub.2 --) and is unsubstituted or substituted by lower alkyl or by phenyl-lower alkyl, R.sub.5, independently of R.sub.2, has one of the meanings mentioned for R.sub.2, and R.sub.6, independently of R.sub.1, is lower alkoxycarbonyl, or salts thereof, provided that at least one salt-forming group is present. The compounds are inhibitors of retroviral aspartate protease and can be used, for example, in the treatment of AIDS. They exhibit outstanding pharmacodynamic properties.
    Patent expiration dates:

    • June 20, 2017
      ✓ 
      Patent use: METHOD FOR TREATING HIV-1 INFECTION
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Bisulfate salt of HIV protease inhibitor
    Patent 6,087,383
    Issued: July 11, 2000
    Inventor(s): Singh; Janak & Pudipeddi; Madhusudhan & Lindrud; Mark D.
    Assignee(s): Bristol-Myers Squibb Company
    The present invention provides the crystalline bisulfate salt of the formula ##STR1## which is found to have unexpectedly high solubility/dissolution rate and oral bioavailability relative to the free base form of this azapeptide HIV protease inhibitor compound.
    Patent expiration dates:

    • December 21, 2018
      ✓ 
      Drug substance
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • March 25, 2011 - NEW PATIENT POPULATION

    • September 30, 2011 - ALTERNATIVE DOSING REGIMEN ATAZANAVIR SULATE CO-ADMINISTERED WITH RITONAVIR FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT NAIVE PATIENTS

    • February 4, 2014 - DOSING RECOMMENDATIONS FOR TREATMENT OF HIV-1 INFECTION DURING PREGNANCY BASED ON DATA FROM STUDY AI424-182, A STUDY OF ATAZANAVIR/RITONAVIR IN COMBINATION WITH ZIDOVUDINE/LAMIVUDINE IN HIV INFECTED PREGNANT WOMEN

See also...

  • Reyataz Consumer Information (Drugs.com)
  • Reyataz Consumer Information (Wolters Kluwer)
  • Reyataz Consumer Information (Cerner Multum)
  • Reyataz Advanced Consumer Information (Micromedex)
  • Reyataz AHFS DI Monographs (ASHP)
  • Atazanavir Consumer Information (Wolters Kluwer)
  • Atazanavir Consumer Information (Cerner Multum)
  • Atazanavir Advanced Consumer Information (Micromedex)
  • Atazanavir Sulfate AHFS DI Monographs (ASHP)

Oxaliplatino Ratiopharm




Oxaliplatino Ratiopharm may be available in the countries listed below.


Ingredient matches for Oxaliplatino Ratiopharm



Oxaliplatin

Oxaliplatin is reported as an ingredient of Oxaliplatino Ratiopharm in the following countries:


  • Italy

  • Spain

International Drug Name Search


Donulide




Donulide may be available in the countries listed below.


Ingredient matches for Donulide



Nimesulide

Nimesulide is reported as an ingredient of Donulide in the following countries:


  • Portugal

International Drug Name Search


Oxprenolol HCl Sandoz




Oxprenolol HCl Sandoz may be available in the countries listed below.


Ingredient matches for Oxprenolol HCl Sandoz



Oxprenolol

Oxprenolol hydrochloride (a derivative of Oxprenolol) is reported as an ingredient of Oxprenolol HCl Sandoz in the following countries:


  • Netherlands

International Drug Name Search


Nilevar




Nilevar may be available in the countries listed below.


Ingredient matches for Nilevar



Norethandrolone

Norethandrolone is reported as an ingredient of Nilevar in the following countries:


  • France

  • Tunisia

International Drug Name Search


Vicks Sinex




UK matches:

  • Vicks Sinex Decongestant Nasal Spray (SPC)
  • Vicks Sinex Micromist (SPC)
  • Vicks Sinex Soother (SPC)

Ingredient matches for Vicks Sinex



Oxymetazoline

Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Vicks Sinex in the following countries:


  • Australia

  • Belgium

  • Finland

  • Italy

  • Luxembourg

  • Malta

  • Netherlands

  • New Zealand

  • Switzerland

  • United Kingdom

  • United States

Phenylephrine

Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Vicks Sinex in the following countries:


  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, October 25, 2016

Domp-M




Domp-M may be available in the countries listed below.


Ingredient matches for Domp-M



Domperidone

Domperidone maleate (a derivative of Domperidone) is reported as an ingredient of Domp-M in the following countries:


  • Thailand

International Drug Name Search


Methanol Poisoning Medications


Drugs associated with Methanol Poisoning

The following drugs and medications are in some way related to, or used in the treatment of Methanol Poisoning. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Methanol Poisoning





Drug List:


Herpes Simplex, Mucocutaneous/Immunocompromised Host Medications


Drugs associated with Herpes Simplex, Mucocutaneous/Immunocompromised Host

The following drugs and medications are in some way related to, or used in the treatment of Herpes Simplex, Mucocutaneous/Immunocompromised Host. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Slow-Trasitensin




Slow-Trasitensin may be available in the countries listed below.


Ingredient matches for Slow-Trasitensin



Chlortalidone

Chlortalidone is reported as an ingredient of Slow-Trasitensin in the following countries:


  • Switzerland

Oxprenolol

Oxprenolol hydrochloride (a derivative of Oxprenolol) is reported as an ingredient of Slow-Trasitensin in the following countries:


  • Switzerland

International Drug Name Search


Sedazine ACP




Sedazine ACP may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sedazine ACP



Acepromazine

Acepromazine maleate (a derivative of Acepromazine) is reported as an ingredient of Sedazine ACP in the following countries:


  • Australia

International Drug Name Search


Ovidrelle




Ovidrelle may be available in the countries listed below.


Ingredient matches for Ovidrelle



Chorionic Gonadotrophin

Chorionic Gonadotrophin alfa (a derivative of Chorionic Gonadotrophin) is reported as an ingredient of Ovidrelle in the following countries:


  • Luxembourg

International Drug Name Search


Vecuron




Vecuron may be available in the countries listed below.


Ingredient matches for Vecuron



Vecuronium

Vecuronium Bromide is reported as an ingredient of Vecuron in the following countries:


  • Argentina

  • Brazil

  • Venezuela

International Drug Name Search


Doxilina




Doxilina may be available in the countries listed below.


Ingredient matches for Doxilina



Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxilina in the following countries:


  • Peru

International Drug Name Search


Ethex Corporation


Address


Ethex Corporation,
One Corporate Woods Drive

St. Louis, MO 63044

Contact Details

Phone: (800) 321-1705
Website: http://www.ethex.com/
Careers: http://www.ethex.com/

Docusate Sodium




Ingredient matches for Docusate Sodium



Dioctyl Sulfosuccinic Acid

Docusate Sodium (BAN, USAN) is also known as Dioctyl Sulfosuccinic Acid



Docusate

Docusate Sodium (BAN, USAN) is known as Docusate in the US.

International Drug Name Search

Glossary

BANBritish Approved Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, October 24, 2016

Spiperone




Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000749-02-0

Chemical Formula

C23-H26-F-N3-O2

Molecular Weight

395

Therapeutic Category

Neuroleptic

Chemical Name

1,3,8-Triazaspiro[4.5]decan-4-one, 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-

Foreign Names

  • Spiperonum (Latin)
  • Spiperon (German)
  • SpipĂ©rone (French)
  • Espiperona (Spanish)

Generic Names

  • Spiperone (OS: USAN, JAN, BAN)
  • E 525 (IS)
  • R 5147 (IS)

Brand Name

  • Spiropitan
    Sannova, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

D-Alfa




D-Alfa may be available in the countries listed below.


Ingredient matches for D-Alfa



Alfacalcidol

Alfacalcidol is reported as an ingredient of D-Alfa in the following countries:


  • Japan

International Drug Name Search


Sulfacetamide




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

S01AB04

CAS registry number (Chemical Abstracts Service)

0000144-80-9

Chemical Formula

C8-H10-N2-O3-S

Molecular Weight

214

Therapeutic Category

Antibacterial: Sulfonamid

Chemical Name

Acetamide, N-[(4-aminophenyl)sulfonyl]-

Foreign Names

  • Sulfacetamidum (Latin)
  • Sulfacetamid (German)
  • SulfacĂ©tamide (French)
  • Sulfacetamida (Spanish)

Generic Names

  • Sulfacetamide (OS: BAN, DCIT)
  • SulfacĂ©tamide (OS: DCF)
  • Sulfanilazetamid (IS)
  • Sulphacetamide (IS)
  • Sulfacetamide (PH: USP 32, Ph. Int. 4)
  • Sulfacetamidum (PH: Ph. Int. 4)
  • Sulfanilacetamidum (PH: Ă–AB 2009)
  • Sulfacetamide Sodium (OS: BANM)
  • SulfacĂ©tamide sodique (PH: Ph. Eur. 6)
  • Sulfacetamide Sodium (PH: BP 2010, Ph. Int. 4, USP 32, Ph. Eur. 6)
  • Sulfacetamide, Soluble (PH: BP 2010)
  • Sulfacetamid-Natrium (PH: Ph. Eur. 6)
  • Sulfacetamidum natricum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

  • Fludroxyl (Sulfacetamide and Neomycin, + Fludrocortisone (veterinary use))
    Laboratoire TVM, France


  • Riacetamid
    Riyad Pharma, Oman


  • S - 40
    Lansier, Peru


  • Solutio Sulfacyli natrii
    Endokriniai, Latvia


  • Sulfacetamida
    Blaskov, Colombia


  • Sulfacyl-Na
    Sanitas, Georgia


  • AK-Sulf
    Akorn, Peru; Akorn, United States


  • Albucid
    Allergan, India; Nicholas, Indonesia


  • Amacin (Sulfacetamide and Neomycin, + Prednisolone, + Polymyxin B sulfate (veterinary use))
    Jurox, Australia


  • Anginamide
    Medgenix, Belgium


  • Antebor
    Kela, Luxembourg; Wolfs, Belgium; Wolfs, Luxembourg


  • Apisulfa
    Amman, Bahrain; Amman Pharmaceutical Industries Co., Oman


  • Aureomix (Sulfacetamide and Chlortetracycline)
    SIT, Italy


  • Blef-10
    Allergan, Colombia; Allergan, Peru


  • Blefamide
    Allergan, Peru


  • Bleph
    Allergan, Australia; Allergan, Bahrain; Allergan, United States


  • Bleph-10
    Allergan, New Zealand; Allergan, United States


  • Blephamide (Sulfacetamide and Prednisolone)
    Allergan, Bahrain; Allergan, Canada; Allergan, Switzerland; Allergan, United States; Pharm Allergan, Germany


  • Brumeton Colloidale S (Sulfacetamide and Betamethasone)
    Bruschettini, Italy


  • Celestone S Coloide (Sulfacetamide and Betamethasone)
    Schering-Plough, Spain


  • Cetamide
    Alcon, United States


  • Cetapred (Sulfacetamide and Prednisolone)
    Alcon, Oman


  • Cetazin
    Sigmapharm, Austria


  • Dermaseb
    Pablo Cassara, Argentina


  • Facetem
    Pascual, Philippines


  • Icid
    Nipa, Bangladesh


  • Isopto Cetamide
    Alcon, Bahrain; Alcon, Botswana; Alcon, Eritrea; Alcon, Ghana; Alcon, Kenya; Alcon, Malawi; Alcon, Namibia; Alcon, Nigeria; Alcon, Tanzania; Alcon, Uganda; Alcon, United States; Alcon, Zambia; Alcon, Zimbabwe


  • Isotic Cetride
    Fahrenheit, Indonesia


  • Klaron
    Dermik, Israel; Sanofi-Aventis, United States


  • Lennon Sulphacetamide
    Aspen Pharmacare Consumer, South Africa


  • Locula
    East India, India


  • Ocusulf
    Miza, United States


  • Oftasul
    Dr. Collado, Dominican Republic


  • Optimide
    Jayson, Bangladesh


  • Optisol
    Fischer, Israel


  • Otenor (Sulfacetamide and Chloramphenicol)
    Rafarm, Greece


  • Paraqueimol
    Aché, Brazil


  • Sivex
    Orva, Turkey


  • Sodium Sulamyd
    Sandoz, Canada


  • Sulf
    Novartis, United States


  • Sulfa 10
    Meda, Belgium


  • Sulfacel
    Optopics, United States


  • Sulfacet
    Oftalmi, Venezuela


  • Sulfacetamid Ofteno
    Sophia, Mexico


  • Sulfacetamida La SantĂ©
    La Santé, Colombia


  • Sulfacetamida Sodica
    Opharm, Colombia


  • Sulfacetamide Sodium 10%
    Perrigo, United States


  • Sulfacetamide Sodium and Prednisolone Sodium Phosphate (Sulfacetamide and Prednisolone disodium phosphate)
    Alcon, United States; Bausch & Lomb, United States; Falcon, United States


  • Sulfacetamide Sodium
    Akorn, United States; Alcon, United States; Bausch & Lomb, United States; Falcon, United States; Fougera, United States; Nycomed, United States; Taro, United States


  • Sulfacetamidum
    Polfa Warszawa, Poland; Polpharma, Poland


  • Sulfacid
    Fischer, Israel


  • Sulfacollyre (Sulfacetamide and Phenylephrine (veterinary use))
    Véto-Centre, France


  • Sulfex
    Xepa-Soul Pattinson, Hong Kong


  • Sulop
    Medifarma, Peru


  • Sulphacetamide-Polpharma
    Polpharma, Czech Republic


  • Vasocidin (Sulfacetamide and Prednisolone)
    Novartis, United States

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Norpril




Norpril may be available in the countries listed below.


Ingredient matches for Norpril



Enalapril

Enalapril is reported as an ingredient of Norpril in the following countries:


  • Peru

International Drug Name Search


Undecin




Undecin may be available in the countries listed below.


Ingredient matches for Undecin



Undecylenic Acid

Undecylenic Acid zinc salt (a derivative of Undecylenic Acid) is reported as an ingredient of Undecin in the following countries:


  • Colombia

International Drug Name Search


Santuril




Santuril may be available in the countries listed below.


Ingredient matches for Santuril



Probenecid

Probenecid is reported as an ingredient of Santuril in the following countries:


  • Switzerland

International Drug Name Search


Neldim




Neldim may be available in the countries listed below.


Ingredient matches for Neldim



Acyclovir

Aciclovir is reported as an ingredient of Neldim in the following countries:


  • Greece

International Drug Name Search


Dytenzide




Dytenzide may be available in the countries listed below.


Ingredient matches for Dytenzide



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Dytenzide in the following countries:


  • Belgium

  • Netherlands

Triamterene

Triamterene is reported as an ingredient of Dytenzide in the following countries:


  • Belgium

  • Netherlands

International Drug Name Search


MS Contin


MS Contin is a brand name of morphine, approved by the FDA in the following formulation(s):


MS CONTIN (morphine sulfate - tablet, extended release; oral)



  • Manufacturer: PURDUE PHARMA LP

    Approval date: May 29, 1987

    Strength(s): 30MG [AB]


  • Manufacturer: PURDUE PHARMA LP

    Approval date: April 8, 1988

    Strength(s): 60MG [AB]


  • Manufacturer: PURDUE PHARMA LP

    Approval date: September 12, 1989

    Strength(s): 15MG [AB]


  • Manufacturer: PURDUE PHARMA LP

    Approval date: January 16, 1990

    Strength(s): 100MG [RLD][AB]


  • Manufacturer: PURDUE PHARMA LP

    Approval date: November 8, 1993

    Strength(s): 200MG [AB]

Has a generic version of MS Contin been approved?


Yes. The following products are equivalent to MS Contin:


morphine sulfate tablet, extended release; oral



  • Manufacturer: CLONMEL HLTHCARE

    Approval date: January 28, 2000

    Strength(s): 15MG [AB]


  • Manufacturer: ENDO PHARMS

    Approval date: October 28, 1998

    Strength(s): 15MG [AB], 30MG [AB], 60MG [AB]


  • Manufacturer: ENDO PHARMS

    Approval date: September 15, 2000

    Strength(s): 100MG [AB], 200MG [AB]


  • Manufacturer: MALLINCKRODT

    Approval date: July 3, 2003

    Strength(s): 100MG [AB], 200MG [AB]


  • Manufacturer: MALLINCKRODT

    Approval date: July 31, 2003

    Strength(s): 15MG [AB], 30MG [AB], 60MG [AB]


  • Manufacturer: MYLAN PHARMS INC

    Approval date: October 18, 2011

    Strength(s): 100MG [AB], 15MG [AB], 200MG [AB], 30MG [AB], 60MG [AB]


  • Manufacturer: NESHER PHARMS

    Approval date: May 19, 2004

    Strength(s): 15MG [AB], 60MG [AB]


  • Manufacturer: NESHER PHARMS

    Approval date: December 23, 2005

    Strength(s): 30MG [AB]


  • Manufacturer: NESHER PHARMS

    Approval date: September 27, 2007

    Strength(s): 100MG [AB], 200MG [AB]


  • Manufacturer: RHODES PHARMS

    Approval date: July 2, 1998

    Strength(s): 100MG [AB], 200MG [AB]


  • Manufacturer: RHODES PHARMS

    Approval date: July 7, 1998

    Strength(s): 15MG [AB], 30MG [AB], 60MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of MS Contin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with MS Contin.

See also...

  • MS Contin Consumer Information (Drugs.com)
  • MS Contin Sustained-Release Tablets Consumer Information (Wolters Kluwer)
  • MS Contin Consumer Information (Cerner Multum)
  • MS Contin Advanced Consumer Information (Micromedex)
  • Morphine Consumer Information (Drugs.com)
  • Morphine Concentrate Consumer Information (Wolters Kluwer)
  • Morphine Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Morphine Immediate-Release Consumer Information (Wolters Kluwer)
  • Morphine Immediate-Release Tablets Consumer Information (Wolters Kluwer)
  • Morphine Soluble Tablets Consumer Information (Wolters Kluwer)
  • Morphine Solution Consumer Information (Wolters Kluwer)
  • Morphine Suppositories Consumer Information (Wolters Kluwer)
  • Morphine Sustained-Release Tablets Consumer Information (Wolters Kluwer)
  • Morphine IR Consumer Information (Cerner Multum)
  • Morphine Consumer Information (Cerner Multum)
  • DepoDur Advanced Consumer Information (Micromedex)
  • Morphine Advanced Consumer Information (Micromedex)
  • Morphine Epidural Advanced Consumer Information (Micromedex)
  • Morphine Injection Advanced Consumer Information (Micromedex)
  • Morphine Sulfate AHFS DI Monographs (ASHP)

Wellvone




Wellvone may be available in the countries listed below.


UK matches:

  • Wellvone 750mg/5ml oral suspension (SPC)

Ingredient matches for Wellvone



Atovaquone

Atovaquone is reported as an ingredient of Wellvone in the following countries:


  • Australia

  • Belgium

  • France

  • Germany

  • Greece

  • Italy

  • Netherlands

  • Portugal

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Autonomic Dysreflexia Medications


There are currently no drugs listed for "Autonomic Dysreflexia".

Learn more about Autonomic Dysreflexia





Drug List:


Happy Jack Worm Capsules




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Happy Jack Worm Capsules



Butyl Chloride

Butyl Chloride is reported as an ingredient of Happy Jack Worm Capsules in the following countries:


  • United States

International Drug Name Search


Sunday, October 23, 2016

Narkamon Spofa




Narkamon Spofa may be available in the countries listed below.


Ingredient matches for Narkamon Spofa



Ketamine

Ketamine hydrochloride (a derivative of Ketamine) is reported as an ingredient of Narkamon Spofa in the following countries:


  • Slovakia

International Drug Name Search


Osetron




Osetron may be available in the countries listed below.


Ingredient matches for Osetron



Ondansetron

Ondansetron hydrochloride (a derivative of Ondansetron) is reported as an ingredient of Osetron in the following countries:


  • Bangladesh

  • Myanmar

  • Romania

  • Sri Lanka

International Drug Name Search


Veramyst




In the US, Veramyst (fluticasone nasal) is a member of the drug class nasal steroids and is used to treat Hay Fever, Nasal Polyps and Rhinitis.

US matches:

  • Veramyst

  • Veramyst Spray

  • Veramyst Nasal

Ingredient matches for Veramyst



Fluticasone

Fluticasone furoate (a derivative of Fluticasone) is reported as an ingredient of Veramyst in the following countries:


  • United States

International Drug Name Search


Scandonest L




In the US, Scandonest L is a member of the drug class local injectable anesthetics.

Ingredient matches for Scandonest L



Corbadrine

Corbadrine is reported as an ingredient of Scandonest L in the following countries:


  • United States

Mepivacaine

Mepivacaine hydrochloride (a derivative of Mepivacaine) is reported as an ingredient of Scandonest L in the following countries:


  • United States

International Drug Name Search


Saturday, October 22, 2016

Somatostatin UCB




Somatostatin-UCB may be available in the countries listed below.


Ingredient matches for Somatostatin-UCB



Somatostatin

Somatostatin is reported as an ingredient of Somatostatin-UCB in the following countries:


  • Greece

  • Indonesia

  • Slovenia

  • Turkey

Somatostatin x acetate (a derivative of Somatostatin) is reported as an ingredient of Somatostatin-UCB in the following countries:


  • Austria

  • Bulgaria

  • Czech Republic

  • Greece

  • Hungary

  • Malaysia

  • Poland

  • Singapore

  • Thailand

International Drug Name Search


Sine-Aid IB




In the US, Sine-Aid IB is a member of the drug class upper respiratory combinations and is used to treat Sinus Symptoms.

Ingredient matches for Sine-Aid IB



Ibuprofen

Ibuprofen is reported as an ingredient of Sine-Aid IB in the following countries:


  • United States

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Sine-Aid IB in the following countries:


  • United States

International Drug Name Search


Heparina Sodica




Heparina Sodica may be available in the countries listed below.


Ingredient matches for Heparina Sodica



Heparin

Heparin sodium salt (a derivative of Heparin) is reported as an ingredient of Heparina Sodica in the following countries:


  • Argentina

  • Chile

  • Colombia

  • Venezuela

International Drug Name Search


Dorzol




Dorzol may be available in the countries listed below.


Ingredient matches for Dorzol



Dorzolamide

Dorzolamide is reported as an ingredient of Dorzol in the following countries:


  • Venezuela

International Drug Name Search


Stacorin




Stacorin may be available in the countries listed below.


Ingredient matches for Stacorin



Citicoline

Citicoline sodium salt (a derivative of Citicoline) is reported as an ingredient of Stacorin in the following countries:


  • Dominican Republic

International Drug Name Search


Decacef




Decacef may be available in the countries listed below.


Ingredient matches for Decacef



Cefalexin

Cefalexin is reported as an ingredient of Decacef in the following countries:


  • Sri Lanka

International Drug Name Search


Scopma Plus




Scopma Plus may be available in the countries listed below.


Ingredient matches for Scopma Plus



Paracetamol

Paracetamol is reported as an ingredient of Scopma Plus in the following countries:


  • Indonesia

Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Scopma Plus in the following countries:


  • Indonesia

International Drug Name Search


Degorflan




Degorflan may be available in the countries listed below.


Ingredient matches for Degorflan



Nimesulide

Nimesulide is reported as an ingredient of Degorflan in the following countries:


  • Mexico

International Drug Name Search


Friday, October 21, 2016

Zanamet




Zanamet may be available in the countries listed below.


Ingredient matches for Zanamet



Ranitidine

Ranitidine is reported as an ingredient of Zanamet in the following countries:


  • Thailand

International Drug Name Search


Denapril




Denapril may be available in the countries listed below.


Ingredient matches for Denapril



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Denapril in the following countries:


  • Portugal

International Drug Name Search


Eating Disorder Medications


Definition of Eating Disorder: The uncontrolled lack or loss of the appetite for food.

Drugs (by generic name) associated with Eating Disorder

The following drugs and medications are in some way related to, or used in the treatment of Eating Disorder. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Topics under Eating Disorder

  • Bulimia (8 drugs)

Learn more about Eating Disorder





Drug List:


Neoduplamox




Neoduplamox may be available in the countries listed below.


Ingredient matches for Neoduplamox



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Neoduplamox in the following countries:


  • Italy

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Neoduplamox in the following countries:


  • Italy

International Drug Name Search


Doxylets




Doxylets may be available in the countries listed below.


Ingredient matches for Doxylets



Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxylets in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search


Duogard




Duogard may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Duogard



Permethrin

Permethrin is reported as an ingredient of Duogard in the following countries:


  • Australia

  • New Zealand

Pyriproxyfen

Pyriproxyfen is reported as an ingredient of Duogard in the following countries:


  • Australia

  • New Zealand

International Drug Name Search


Biogen Idec


Address


Biogen Idec,
14 Cambridge Center

Cambridge, MA 02142

Contact Details

Phone: (617) 679-2000
Website: http://www.biogenidec.com/
Careers: http://www.biogenidec.com/CAREERS.aspx?ID=5424

Urinary Tract Infection Medications


Definition of Urinary Tract Infection: A urinary tract infection, or UTI, is an infection that can happen anywhere along the urinary tract -- the kidneys, the ureters (the tubes that take urine from each kidney to the bladder), the bladder, or the urethra (the tube that empties urine from the bladder to the outside). Most commonly, infections affect the lower urinary tract (bladder and urethra), which is called cystitis. More...

Drugs associated with Urinary Tract Infection

The following drugs and medications are in some way related to, or used in the treatment of Urinary Tract Infection. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Urinary Tract Infection

  • Bladder Infection (74 drugs in 4 topics)

  • Kidney Infections (65 drugs)

  • Urinary Acidification (30 drugs)

  • Urinary Alkalinization (12 drugs)

Learn more about Urinary Tract Infection





Drug List:


Virocomb-N




Virocomb-N may be available in the countries listed below.


Ingredient matches for Virocomb-N



Lamivudine

Lamivudine is reported as an ingredient of Virocomb-N in the following countries:


  • Myanmar

Nevirapine

Nevirapine is reported as an ingredient of Virocomb-N in the following countries:


  • Myanmar

Zidovudine

Zidovudine is reported as an ingredient of Virocomb-N in the following countries:


  • Myanmar

International Drug Name Search


Viibryd


Viibryd is a brand name of vilazodone, approved by the FDA in the following formulation(s):


VIIBRYD (vilazodone hydrochloride - tablet; oral)



  • Manufacturer: FOREST LABS INC

    Approval date: January 21, 2011

    Strength(s): 10MG, 20MG, 40MG [RLD]

Has a generic version of Viibryd been approved?


No. There is currently no therapeutically equivalent version of Viibryd available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Viibryd. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Piperidines and piperazines
    Patent 5,532,241
    Issued: July 2, 1996
    Inventor(s): Bottcher; Henning & Seyfried; Christoph & Bartoszyk; Gerd & Greiner; Hartmut
    Assignee(s): Merck Patent Gesellschaft mit beschrankter Haftung
    Piperidine and piperazine derivatives of the formula I ##STR1## wherein Ind is an indol-3-yl radical which is unsubstituted or mono- or polysubstituted by OH, OA, CN, Hal, COR.sup.2 or CH.sub.2 R.sup.2, R.sup.1 is benzofuran-5-yl or 2,3-dihydrobenzofuran-5-yl, chroman-6-yl, chroman-4-on-6-yl, 3-chromen-6-yl or chromen-4-on-6-yl, which is unsubstituted or monosubstituted by CN, CH.sub.2 OH, CH.sub.2 OA or COR.sup.2, Q is C.sub.m H.sub.2m, N or CR.sup.3, A is alkyl having 1-6 C atoms, Hal is F, C1, Br or I, R.sup.2 is OH, OA, NH.sub.2, NHA or NA.sub.2, R.sup.3 is H, OH or OA and m is 2, 3 or 4, and their physiologically acceptable salts, are active on the central nervous system.
    Patent expiration dates:

    • September 29, 2014
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
    Patent 7,834,020
    Issued: November 16, 2010
    Inventor(s): Bathe; Andreas & Helfert; Bernd & Neuenfeld; Steffen & Kniel; Heike & Bartels; Matthias & Rudolph; Susanne & Böttcher; Henning
    Assignee(s): Merck Patent Gesellschaft
    The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular for the preparation of solid medicaments for the treatment or prevention of depressive disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and undesired puerperal lactation.
    Patent expiration dates:

    • June 5, 2022
      ✓ 
      Patent use: TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
      ✓ 
      Drug substance
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • January 21, 2016 - NEW CHEMICAL ENTITY

See also...

  • Viibryd Consumer Information (Drugs.com)
  • Viibryd Consumer Information (Wolters Kluwer)
  • Viibryd Consumer Information (Cerner Multum)
  • Viibryd Advanced Consumer Information (Micromedex)
  • Vilazodone Consumer Information (Wolters Kluwer)
  • Vilazodone Consumer Information (Cerner Multum)
  • Vilazodone Advanced Consumer Information (Micromedex)

Nafacil




Nafacil may be available in the countries listed below.


Ingredient matches for Nafacil



Cefalexin

Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Nafacil in the following countries:


  • Mexico

International Drug Name Search


Thursday, October 20, 2016

Fluid Retention Medications


Definition of Fluid Retention: An abnormal accumulation of fluid in cells, tissues or body cavities that results in swelling.

Drugs associated with Fluid Retention

The following drugs and medications are in some way related to, or used in the treatment of Fluid Retention. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Topics under Fluid Retention

  • Edema (31 drugs in 2 topics)

  • Intravascular Volume Depletion (0 drugs)

Learn more about Fluid Retention





Drug List:


Lescol


See also: Generic Lescol XL


Lescol is a brand name of fluvastatin, approved by the FDA in the following formulation(s):


LESCOL (fluvastatin sodium - capsule; oral)



  • Manufacturer: NOVARTIS

    Approval date: December 31, 1993

    Strength(s): EQ 20MG BASE, EQ 40MG BASE [RLD]

Has a generic version of Lescol been approved?


No. There is currently no therapeutically equivalent version of Lescol available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lescol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Indole analogs of mevalonolactone and derivatives thereof
    Patent 5,354,772
    Issued: October 11, 1994
    Inventor(s): Kathawala; Faizulla G.
    Assignee(s): Sandoz Pharm. Corp.
    Compounds of the formula ##STR1## wherein one of R and R.sub.o is ##STR2## and the other is primary or secondary C.sub.1-6 alkyl not containing an asymmetric carbon atom, C.sub.3-6 cycloalkyl or phenyl-(CH.sub.2).sub.m --, wherein R.sub.4 is hydrogen, C.sub.1-3 alkyl, n-butyl, i-butyl, t-butyl, C.sub.1-3 alkoxy, n-butoxy, i-butoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, R.sub.5 is hydrogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, R.sub.5a is hydrogen, C.sub.1-2 alkyl, C.sub.1-2 alkoxy, fluoro or chloro, and m is 1, 2 or 3, with the provisos that both R.sub.5 and R.sub.5a must be hydrogen when R.sub.4 is hydrogen, R.sub.5a must be hydrogen when R.sub.5 is hydrogen, not more than one of R.sub.4 and R.sub.5 is trifluoromethyl, not more than one of R.sub.4 and R.sub.5 is phenoxy, and not more than one of R.sub.4 and R.sub.5 is benzyloxy, R.sub.2 is hydrogen, C.sub.1-3 alkyl, n-butyl, i-butyl, t-butyl, C.sub.3-6 cycloalkyl, C.sub.1-3 alkoxy, n-butoxy, i-butoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, R.sub.3 is hydrogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, trifluoromethyl, fluoro, chloro, phenoxy or benzyloxy, with the provisos that R.sub.3 must be hydrogen when R.sub.2 is hydrogen, not more than one of R.sub.2 and R.sub.3 is trifluoromethyl, not more than one of R.sub.2 and R.sub.3 is phenoxy, and not more than one of R.sub.2 and R.sub.3 is benzyloxy, X is --(CH.sub.2).sub.n -- or --CH.dbd.CH--, wherein n is 0, 1, 2 or 3, and Z is ##STR3## wherein R.sub.6 is hydrogen or C.sub.1-3 alkyl, and R.sub.7 is hydrogen, R.sub.7b or M, wherein R.sub.7b is a physiologically acceptable and hydrolyzable ester group, and M is a pharmaceutically acceptable cation, the use thereof for inhibiting cholesterol biosynthesis and lowering the blood cholesterol level, and therefore, in the treatment of hyperliopoproteinemia and atherosclerosis, pharmaceutical compositions comprising such compounds and processes for and intermediates in the synthesis of such compounds.
    Patent expiration dates:

    • October 11, 2011
      ✓ 
      Patent use: ADJUNCT DIET IN THE TX OF ELEVATED TOTAL CHOLESTEROL AND LDL-C LEVELS IN PTS W/PRIMARY HYPERCHOLESTEROLEMIA WHOSE RESPONSE TO DIETARY RESTRICTION OF SAT FAT AND CHOLESTEROL AND OTHER NONPHARMACOLOGICAL MEASURES HAS NOT BEEN ADEQUATE


    • October 11, 2011
      ✓ 
      Patent use: USE OF THE ACTIVE INGREDIENT FOR INHIBITING THE BIOSYNTHESIS OF CHOLESTEROL AND TREATMENT OF ATHEROSCLEROSIS


    • April 11, 2012
      ✓ 
      Pediatric exclusivity




  • Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound
    Patent 5,356,896
    Issued: October 18, 1994
    Inventor(s): Kabadi; Mohan B. & Vivilecchia; Richard V.
    Assignee(s): Sandoz Ltd.
    A pharmaceutical dosage form comprising an HMG-CoA reductase inhibitor compound, e.g., fluvastatin sodium, is disclosed which is stabilized against pH-related degradation by an alkaline stabilizing medium capable of imparting a pH of at least 8 to an aqueous solution or dispersion of the composition.
    Patent expiration dates:

    • December 12, 2011


    • June 12, 2012
      ✓ 
      Pediatric exclusivity



See also...

  • Lescol Consumer Information (Drugs.com)
  • Lescol Consumer Information (Wolters Kluwer)
  • Lescol Consumer Information (Cerner Multum)
  • Lescol Advanced Consumer Information (Micromedex)
  • Lescol AHFS DI Monographs (ASHP)
  • Fluvastatin Consumer Information (Wolters Kluwer)
  • Fluvastatin Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Fluvastatin Consumer Information (Cerner Multum)
  • Fluvastatin Advanced Consumer Information (Micromedex)
  • Fluvastatin Sodium AHFS DI Monographs (ASHP)

Diidrocodeina




Diidrocodeina may be available in the countries listed below.


Ingredient matches for Diidrocodeina



Dihydrocodeine

Diidrocodeina (DCIT) is known as Dihydrocodeine in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Zentavion




Zentavion may be available in the countries listed below.


Ingredient matches for Zentavion



Azithromycin

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Zentavion in the following countries:


  • Spain

International Drug Name Search


Nicepie




Nicepie may be available in the countries listed below.


Ingredient matches for Nicepie



Beclometasone

Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Nicepie in the following countries:


  • Japan

International Drug Name Search


Netilyn




Netilyn may be available in the countries listed below.


Ingredient matches for Netilyn



Netilmicin

Netilmicin sulfate (a derivative of Netilmicin) is reported as an ingredient of Netilyn in the following countries:


  • Finland

  • Iceland

  • Sweden

International Drug Name Search


Wednesday, October 19, 2016

Yarox




Yarox may be available in the countries listed below.


Ingredient matches for Yarox



Cefpirome

Cefpirome sulfate (a derivative of Cefpirome) is reported as an ingredient of Yarox in the following countries:


  • Indonesia

International Drug Name Search


Sintodim




Sintodim may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sintodim



Dimetridazole

Dimetridazole is reported as an ingredient of Sintodim in the following countries:


  • United Kingdom

International Drug Name Search


Normalip




Normalip may be available in the countries listed below.


Ingredient matches for Normalip



Atorvastatin

Atorvastatin is reported as an ingredient of Normalip in the following countries:


  • Argentina

International Drug Name Search


Zirtene




Zirtene may be available in the countries listed below.


Ingredient matches for Zirtene



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Zirtene in the following countries:


  • Ireland

International Drug Name Search


Uniren




Uniren may be available in the countries listed below.


Ingredient matches for Uniren



Diclofenac

Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Uniren in the following countries:


  • Singapore

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Uniren in the following countries:


  • Myanmar

International Drug Name Search


Vinpocetin Covex




Vinpocetin Covex may be available in the countries listed below.


Ingredient matches for Vinpocetin Covex



Vinpocetine

Vinpocetine is reported as an ingredient of Vinpocetin Covex in the following countries:


  • Hungary

  • Latvia

International Drug Name Search


Norilet




Norilet may be available in the countries listed below.


Ingredient matches for Norilet



Norfloxacin

Norfloxacin is reported as an ingredient of Norilet in the following countries:


  • Myanmar

  • Peru

  • Sri Lanka

  • Venezuela

International Drug Name Search


Ulcomet




Ulcomet may be available in the countries listed below.


Ingredient matches for Ulcomet



Cimetidine

Cimetidine is reported as an ingredient of Ulcomet in the following countries:


  • Hong Kong

Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ulcomet in the following countries:


  • Greece

International Drug Name Search


Tuesday, October 18, 2016

Ulfamet




Ulfamet may be available in the countries listed below.


Ingredient matches for Ulfamet



Famotidine

Famotidine is reported as an ingredient of Ulfamet in the following countries:


  • Thailand

International Drug Name Search


Omeprazol Mylan




Omeprazol Mylan may be available in the countries listed below.


Ingredient matches for Omeprazol Mylan



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Mylan in the following countries:


  • Denmark

  • Sweden

International Drug Name Search


Tobrex


Tobrex is a brand name of tobramycin ophthalmic, approved by the FDA in the following formulation(s):


TOBREX (tobramycin - ointment; ophthalmic)



  • Manufacturer: ALCON

    Approved Prior to Jan 1, 1982

    Strength(s): 0.3% [RLD]

TOBREX (tobramycin - solution/drops; ophthalmic)



  • Manufacturer: FALCON PHARMS

    Approved Prior to Jan 1, 1982

    Strength(s): 0.3% [RLD][AT]

Has a generic version of Tobrex been approved?


Yes. The following products are equivalent to Tobrex:


AKTOB (tobramycin solution/drops; ophthalmic)



  • Manufacturer: AKORN

    Approval date: January 31, 1996

    Strength(s): 0.3% [AT]

tobramycin solution/drops; ophthalmic



  • Manufacturer: BAUSCH AND LOMB

    Approval date: November 29, 1993

    Strength(s): 0.3% [AT]


  • Manufacturer: FERA PHARMS

    Approval date: September 11, 2001

    Strength(s): 0.3% [AT]


  • Manufacturer: NOVEX

    Approval date: February 25, 2002

    Strength(s): 0.3% [AT]

Note: No generic formulation of the following product is available.


  • tobramycin - ointment; ophthalmic

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tobrex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Tobrex.

See also...

  • Tobrex Drops Consumer Information (Wolters Kluwer)
  • Tobrex Ointment Consumer Information (Wolters Kluwer)
  • Tobrex Consumer Information (Cerner Multum)
  • Tobrex Advanced Consumer Information (Micromedex)
  • Tobramycin Drops Consumer Information (Wolters Kluwer)
  • Tobramycin Ointment Consumer Information (Wolters Kluwer)
  • Tobramycin ophthalmic Consumer Information (Cerner Multum)
  • Apo-Tobramycin Advanced Consumer Information (Micromedex)
  • Sab-Tobramycin Advanced Consumer Information (Micromedex)
  • Tobramycin Ophthalmic Advanced Consumer Information (Micromedex)
  • Tobramycin eent AHFS DI Monographs (ASHP)

Hexaminolevulinate Hydrochloride




Scheme

USAN

ATC (Anatomical Therapeutic Chemical Classification)

V04CX

CAS registry number (Chemical Abstracts Service)

0140898-91-5

Chemical Formula

C11-H21-N-O3·HCl

Molecular Weight

251

Therapeutic Category

Diagnostic agent

Chemical Names

4-Hexyloxycarbonyl-2-oxobutylammoniumchlorid (IUPAC)

Hexyl 5-amino-4-oxopentanoate hydrochloride (USAN)

Pentanoic acid, 5-amino-4-oxo-, hexyl ester, hydrochloride (USAN)

Foreign Name

  • Hexyl(5-amino-4-oxopentanoat)-hydrochlorid (German)

Generic Names

  • Hexaminolevulinate Hydrochloride (OS: USAN)
  • 5-Amino-4-oxopentansäurehexylester-hydrochlorid (IS)
  • P-1026 (IS: PhotoCure)

Brand Names

  • Hexvix
    Amersham, Spain; GE Healthcare, Austria; GE Healthcare, Belgium; GE Healthcare, Switzerland; GE Healthcare, Germany; GE Healthcare, Estonia; GE Healthcare, France; GE Healthcare, Lithuania; GE Healthcare, Luxembourg; GE Healthcare, Latvia; GE Healthcare, Malta; Health Pharma, Italy; Photocure, Denmark; Photocure, Finland; Photocure, Norway; Photocure, Sweden; Photocure, Slovenia

International Drug Name Search

Glossary

IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.